on OCTOPUS ROBOTS (EPA:MLOCT)
Renewal of the observation period for Octopus Biosafety
Octopus Biosafety, in receivership since May 24, 2024, has had its observation period renewed. The Commercial Court of Lorient, on the basis of an offer favorably received by the Board of Directors, extended this period on November 22, 2024.
The move is intended to allow the company to finalise a capital increase and prepare a recovery plan. However, the renewal is dependent on the payment of a first tranche of financing.
A hearing will be held on December 13, 2024 to verify receipt of these funds. Failure to do so could result in compulsory liquidation.
Octopus Biosafety is listed on Euronext Access Paris (ISIN code FR0013310281).
R. H.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all OCTOPUS ROBOTS news